jama semaglutide GLP1 medicines now address weight loss and other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety. https://ja.ma/3JZg8l3 weight regain and cardiometabolic effects
Description
Weve been bugging the California Board of Pharmacy (politely!) for a while, trying to get a statement on its position and enforcement posture regarding the compounding of FDA-approved drugs that are currently in shortage

The expansion of GLP-1 drug efficacy evidence in 2024, a concise review by Daniel Drucker, a pioneer of the field | 28 comments on LinkedIn
Periconceptional GLP-1 receptor agonist exposure and obstetric outcomes: a Danish nationwide cohort study

Elyse used a compound version of Ozempic for a year to lose weight

Think again

Access a detailed semaglutide dosing chart, including initiation, titration, and maintenance phases, to optimize weight loss and diabetes treatment outcomes.